Hypericum para Interacción farmacológica (Reducción de eficacia)
Hypericum choisyanum — 6 estudios científicos revisados
Strong¿Sirve Hypericum para interacción farmacológica (reducción de eficacia)?
La activación del receptor de pregnano X (PXR) induce enzimas metabólicas que degradan otros medicamentos más rápidamente de lo normal.
Compuestos activos involucrados: Alcaloides, Flavonoides, Polifenoles, Terpenos
Evidencia Científica
Los siguientes estudios han investigado la relación entre Hypericum y interacción farmacológica (reducción de eficacia):
The Phytochemistry and Pharmacology of Hypericum.
Hypericum L. is a genus of the family Hypericaceae within the dicotyledones. The constituents of Hypericum species are valued for their important biological properties. Their use is in the treatment of depression and as antibacterial agents has been well documented in the primary literature and in ethnobotanical reports. The present contribution gives a comprehensive summary of the chemical constituents of members of the genus Hypericum and their biological effects.
PubMed: 33306173Plants from the genus Hypericum, one genus of the Hypericaceae family, have attracted a lot of attention for their potential pharmaceutical applications. Most of the studies in the literature focus on H. perforatum L. (common St. John's wort), whose complex spectrum of bioactive compounds makes this species one of the top herbal remedies and supplements in the world.
PubMed: 31556858Ethnopharmacology of Hypericum species in China: A comprehensive review on ethnobotany, phytochemistry and pharmacology.
ETHNOPHARMACOLOGICAL RELEVANCE: Hypericum species have been used traditionally as astringent, antipyretic, diuretic, antiphlogistic, analgesic, and antidepressant in Europe, America, Africa, and Asia. One of the most extensively investigated medicinal herbs, H. perforatum L. (St. John's wort), is widely used in many countries to treat mild to moderate mental depression.
PubMed: 32101776Hypericin: chemical synthesis and biosynthesis.
Hypericin is one of the most important phenanthoperylene quinones extracted mainly from plants of the genus Hypericum belonging to the sections Euhypericum and Campylosporus of Keller's classification. Widespread attention to the antiviral and anti-tumor properties of hypericin has spurred investigations of the chemical synthesis and biosynthesis of this unique compound. However, the synthetic strategies are challenging for organic and biological chemists. In this review, specific significant advances in total synthesis, semi-synthesis, and biosynthesis in the past decades are summarized.
PubMed: 24636057Hypericum perforatum: a comprehensive review on pharmacognosy, preclinical studies, putative molecular mechanism, and clinical studies in neurodegenerative diseases.
The herb Hypericum perforatum, also referred to as St. John's wort, has drawn a lot of interest because of its potential therapeutic benefits in treating neurodegenerative illnesses. Due to the absence of effective therapies, illnesses like Alzheimer's and Parkinson's disease pose an increasing worldwide health concern. Because of its wide variety of phytochemicals, especially hyperforin, and hypericin, Hypericum perforatum is well known for its neuroprotective properties. These substances have proven to be able to affect different cellular processes linked to neurodegeneration.
PubMed: 38175276Seguridad y Precauciones
El uso de plantas del género Hypericum requiere una precaución extrema debido a su compleja farmacocinética y su capacidad para alterar los sistemas enzimáticos del cuerpo. En el caso del embarazo y la lactancia, el uso de estas especies está estrictamente contraindicado. No existe evidencia suficiente que garantice la seguridad fetal, y existe el riesgo de que los compuestos bioactivos, como la hiperforina, atraviesen la barrera placentaria o se excreten en la leche materna, afectando potencialmente el desarrollo neurológico del neonato. Dado que los efectos sobre el sistema de neurotransmisores son potentes, el riesgo de toxicidad en organismos en desarrollo es una preocupación clínica mayor. Para niños menores de 12 años, el uso no está recomendado. El sistema nervioso infantil es altamente sensible a las modulaciones de neurotransmisores (como la actividad colinérgica mencionada en la literatura) y la falta de estudios de seguridad en poblaciones pediátricas hace que cualquier intervención sea riesgosa.
Otras plantas estudiadas para Interacción farmacológica (Reducción de eficacia)
Perfil completo: Ver todos los usos y evidencia de Hypericum →